NCT00689741View on ClinicalTrials.gov

Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

PHASE2CompletedINTERVENTIONAL
Enrollment

1,113

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL

Cervarix

3 doses of IM injection

BIOLOGICAL

placebo

3 doses of IM injection of Al(OH)3 placebo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY